Literature DB >> 21082080

Identification of dihydropyridines that reduce cellular tau levels.

Christopher G Evans1, Umesh K Jinwal, Leah N Makley, Chad A Dickey, Jason E Gestwicki.   

Abstract

A series of dihydropyridines were identified that have an effect on the accumulation of tau, an important target in Alzheimer's disease. The dihydropyridine collection was expanded using the Hantzsch multicomponent reaction to develop preliminary structure-activity relationships.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21082080      PMCID: PMC3251959          DOI: 10.1039/c0cc02253e

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  14 in total

1.  The natively unfolded character of tau and its aggregation to Alzheimer-like paired helical filaments.

Authors:  Sadasivam Jeganathan; Martin von Bergen; Eva-Maria Mandelkow; Eckhard Mandelkow
Journal:  Biochemistry       Date:  2008-09-11       Impact factor: 3.162

2.  Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines.

Authors:  C M Wischik; P C Edwards; R Y Lai; M Roth; C R Harrington
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

Review 3.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

4.  Synthesis of new acridines and hydrazones derived from cyclic beta-diketone for cytotoxic and antiviral evaluation.

Authors:  Osama I el-Sabbagh; Hanaa M Rady
Journal:  Eur J Med Chem       Date:  2009-04-08       Impact factor: 6.514

Review 5.  Tau mutations in neurodegenerative diseases.

Authors:  Michael S Wolfe
Journal:  J Biol Chem       Date:  2008-10-22       Impact factor: 5.157

6.  Blocking Abeta42 accumulation delays the onset and progression of tau pathology via the C terminus of heat shock protein70-interacting protein: a mechanistic link between Abeta and tau pathology.

Authors:  Salvatore Oddo; Antonella Caccamo; Bert Tseng; David Cheng; Vitaly Vasilevko; David H Cribbs; Frank M LaFerla
Journal:  J Neurosci       Date:  2008-11-19       Impact factor: 6.167

Review 7.  Tau pathophysiology in neurodegeneration: a tangled issue.

Authors:  Tara L Spires-Jones; William H Stoothoff; Alix de Calignon; Phillip B Jones; Bradley T Hyman
Journal:  Trends Neurosci       Date:  2009-01-21       Impact factor: 13.837

8.  Enantioselective organocatalytic Hantzsch synthesis of polyhydroquinolines.

Authors:  Christopher G Evans; Jason E Gestwicki
Journal:  Org Lett       Date:  2009-07-16       Impact factor: 6.005

Review 9.  Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases.

Authors:  Michael P Mazanetz; Peter M Fischer
Journal:  Nat Rev Drug Discov       Date:  2007-06       Impact factor: 84.694

Review 10.  Chaperone signalling complexes in Alzheimer's disease.

Authors:  John Koren; Umesh K Jinwal; Daniel C Lee; Jeffrey R Jones; Cody L Shults; Amelia G Johnson; Laura J Anderson; Chad A Dickey
Journal:  J Cell Mol Med       Date:  2009-04       Impact factor: 5.310

View more
  11 in total

Review 1.  Alzheimer mechanisms and therapeutic strategies.

Authors:  Yadong Huang; Lennart Mucke
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

2.  Transcriptional Inhibitors Identified in a 160,000-Compound Small-Molecule DUX4 Viability Screen.

Authors:  Si Ho Choi; Darko Bosnakovski; Jessica M Strasser; Erik A Toso; Michael A Walters; Michael Kyba
Journal:  J Biomol Screen       Date:  2016-05-31

Review 3.  Tau Protein Squired by Molecular Chaperones During Alzheimer's Disease.

Authors:  Nalini Vijay Gorantla; Subashchandrabose Chinnathambi
Journal:  J Mol Neurosci       Date:  2018-09-28       Impact factor: 3.444

4.  DnaJA1 antagonizes constitutive Hsp70-mediated stabilization of tau.

Authors:  Jose F Abisambra; Umesh K Jinwal; Amirthaa Suntharalingam; Karthik Arulselvam; Sarah Brady; Matthew Cockman; Ying Jin; Bo Zhang; Chad A Dickey
Journal:  J Mol Biol       Date:  2012-02-15       Impact factor: 5.469

5.  Intercepted-Knoevenagel condensation for the synthesis of unsymmetrical fused-tricyclic 4H-pyrans.

Authors:  Charles Shearer; Oriane Desaunay; Stephen Zorc; Alexis D Richaud; Shyam S Samanta; Nagalakshmi Jeedimalla; Stéphane P Roche
Journal:  Tetrahedron       Date:  2019-09-17       Impact factor: 2.457

6.  Pharmacological tuning of heat shock protein 70 modulates polyglutamine toxicity and aggregation.

Authors:  Sidhartha M Chafekar; Susanne Wisén; Andrea D Thompson; AnaLisa Echeverria; Gladis M Walter; Christopher G Evans; Leah N Makley; Jason E Gestwicki; Martin L Duennwald
Journal:  ACS Chem Biol       Date:  2012-06-22       Impact factor: 5.100

7.  Lanthanide and asymmetric catalyzed syntheses of sterically hindered 4-isoxazolyl-1,4-dihydropyridines and 4-isoxazolyl-quinolones.

Authors:  Scott A Steiger; Chun Li; Charles F Campana; Nicholas R Natale
Journal:  Tetrahedron Lett       Date:  2016-01-20       Impact factor: 2.415

Review 8.  The molecular diversity scope of 1,3-indandione in organic synthesis.

Authors:  Shima Asadi; Ghodsi Mohammadi Ziarani
Journal:  Mol Divers       Date:  2015-05-10       Impact factor: 2.943

9.  Specific calpain inhibition by calpastatin prevents tauopathy and neurodegeneration and restores normal lifespan in tau P301L mice.

Authors:  Mala V Rao; Mary Kate McBrayer; Jabbar Campbell; Asok Kumar; Audrey Hashim; Henry Sershen; Philip H Stavrides; Masuo Ohno; Michael Hutton; Ralph A Nixon
Journal:  J Neurosci       Date:  2014-07-09       Impact factor: 6.167

10.  3-Acetyl-2-methyl-4-(pyridin-3-yl)-1,4-di-hydro-indeno-[1,2-b]pyridin-5-one.

Authors:  Imants Bisenieks; Anatoly Mishnev; Imanta Bruvere; Brigita Vigante; Zigmars Andzans
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.